Gudbjörg Ragna Sigurjonsdottir

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/3630da29-2c58-4459-99c3-133f70cfcd98?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
Sigurjonsdottir, Gudbjörg ^LU ; De Marchi, Tommaso ^LU ; Ehinger, Anna ^LU ; Hartman, Johan ; Ullén, Susann ^LU ; Leandersson, Karin ^LU ; Bosch, Ana ^LU ; Staaf, Johan ^LU ; Killander, Fredrika ^LU and Niméus, Emma ^LU (2025) In Breast Cancer Research and Treatment 210(2). p.271-284
- Contribution to journal › Article
Mark Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
Ekedahl, Henrik ^LU ; Sigurjonsdottir, Gudbjörg ^LU ; Bergqvist, Viktoria ^LU ; Båtshake, Björn ^LU ; Carneiro, Ana ^LU and Marsal, Jan ^LU (2025) In Acta oncologica (Stockholm, Sweden) 64. p.1365-1370
- Contribution to journal › Scientific review
2023
Mark Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
Sigurjonsdottir, Gudbjörg ^LU ; De Marchi, Tommaso ^LU ; Ehinger, Anna ^LU ; Hartman, Johan ; Bosch, Ana ^LU ; Staaf, Johan ^LU ; Killander, Fredrika ^LU and Niméus, Emma ^LU (2023) In Breast Cancer Research 25(1).
- Contribution to journal › Article